[
  {
    "ts": null,
    "headline": "Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks",
    "summary": "A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete with larger life-science companies, but integration risks can’t be discounted, analysts say.",
    "url": "https://finnhub.io/api/news?id=505be939ad3ff2a4d2eef55e74ae6885a0c0636b76ff19d999be2ccae10ecc01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752605220,
      "headline": "Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks",
      "id": 135960672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete with larger life-science companies, but integration risks can’t be discounted, analysts say.",
      "url": "https://finnhub.io/api/news?id=505be939ad3ff2a4d2eef55e74ae6885a0c0636b76ff19d999be2ccae10ecc01"
    }
  },
  {
    "ts": null,
    "headline": "Waters Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "Waters Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=280635c667843bc7ae63fc8ae0ddcf6c0b1c8afa44af794949ed7b74a1dfa705",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752597000,
      "headline": "Waters Corp. stock underperforms Tuesday when compared to competitors",
      "id": 135989670,
      "image": "",
      "related": "WAT",
      "source": "MarketWatch",
      "summary": "Waters Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=280635c667843bc7ae63fc8ae0ddcf6c0b1c8afa44af794949ed7b74a1dfa705"
    }
  },
  {
    "ts": null,
    "headline": "Waters, BD Bioscience deal ‘looks to be a good fit,’ says Stifel",
    "summary": "Waters (WAT) announced that it is combining with BD’s (BDX) Bioscience and Diagnostics business in a tax-efficient Reverse Morris Trust transaction that is valued at roughly $17.5B, marking a major strategic step for Waters, as the deal is large and transformative, Stifel analyst Daniel Arias tells investors in a research note. The move looks to be a good fit, though the size and complexity of the deal has to be acknowledged, Stifel says. Published first on TheFly – the ultimate source for real-",
    "url": "https://finnhub.io/api/news?id=f4bab64bae0b7722f77b6950969e6a456b2e93269361278021d8fcaf4306f51f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752589554,
      "headline": "Waters, BD Bioscience deal ‘looks to be a good fit,’ says Stifel",
      "id": 135960673,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters (WAT) announced that it is combining with BD’s (BDX) Bioscience and Diagnostics business in a tax-efficient Reverse Morris Trust transaction that is valued at roughly $17.5B, marking a major strategic step for Waters, as the deal is large and transformative, Stifel analyst Daniel Arias tells investors in a research note. The move looks to be a good fit, though the size and complexity of the deal has to be acknowledged, Stifel says. Published first on TheFly – the ultimate source for real-",
      "url": "https://finnhub.io/api/news?id=f4bab64bae0b7722f77b6950969e6a456b2e93269361278021d8fcaf4306f51f"
    }
  },
  {
    "ts": null,
    "headline": "Waters deal adds variables to ‘clean’ story, says Jefferies",
    "summary": "Jefferies expects shares of Waters (WAT) to trade down on the combination with Beckton Dickinson (BDX) via a reverse merger trust due to the deal size and “variables added to a clean replacement cycle story.” However, longer term, Jefferies likes the merits of the deal, saying it creates real scale, which has proven effective in the space. It keeps a Buy rating on Waters, which is trading down 13% to $306.92 in morning trading. Published first on TheFly – the ultimate source for real-time, marke",
    "url": "https://finnhub.io/api/news?id=22aa67a85a74442b4fd638a441372afcd67fbc873e8c54f57107635c343a6aa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752589519,
      "headline": "Waters deal adds variables to ‘clean’ story, says Jefferies",
      "id": 135960674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Jefferies expects shares of Waters (WAT) to trade down on the combination with Beckton Dickinson (BDX) via a reverse merger trust due to the deal size and “variables added to a clean replacement cycle story.” However, longer term, Jefferies likes the merits of the deal, saying it creates real scale, which has proven effective in the space. It keeps a Buy rating on Waters, which is trading down 13% to $306.92 in morning trading. Published first on TheFly – the ultimate source for real-time, marke",
      "url": "https://finnhub.io/api/news?id=22aa67a85a74442b4fd638a441372afcd67fbc873e8c54f57107635c343a6aa5"
    }
  },
  {
    "ts": null,
    "headline": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
    "summary": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=d87e84eb6b8f6fd172e66a455ebafff5d63cb33e2fafe284d429a76111518c91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752587256,
      "headline": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
      "id": 135948434,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=d87e84eb6b8f6fd172e66a455ebafff5d63cb33e2fafe284d429a76111518c91"
    }
  },
  {
    "ts": null,
    "headline": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
    "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
    "url": "https://finnhub.io/api/news?id=4bcf5f5e012898e050ecb56885d316338fcde4dbb8ff245487958b43cb83af78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752585120,
      "headline": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
      "id": 135960676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
      "url": "https://finnhub.io/api/news?id=4bcf5f5e012898e050ecb56885d316338fcde4dbb8ff245487958b43cb83af78"
    }
  },
  {
    "ts": null,
    "headline": "BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal",
    "summary": "The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026.",
    "url": "https://finnhub.io/api/news?id=52c12595f44501ddf9309638d8b8d7882afef0d63166a46063e2e54d131d5a4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752576985,
      "headline": "BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal",
      "id": 135943659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026.",
      "url": "https://finnhub.io/api/news?id=52c12595f44501ddf9309638d8b8d7882afef0d63166a46063e2e54d131d5a4c"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business",
    "summary": "Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A and why I remain bullish on BDX.",
    "url": "https://finnhub.io/api/news?id=e5fb8617d2016f1c9f9fdd05afabb3289214e4c8d382791c9c93bbc3028a3309",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752564481,
      "headline": "Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business",
      "id": 135941969,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323538000/image_1323538000.jpg?io=getty-c-w1536",
      "related": "WAT",
      "source": "SeekingAlpha",
      "summary": "Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A and why I remain bullish on BDX.",
      "url": "https://finnhub.io/api/news?id=e5fb8617d2016f1c9f9fdd05afabb3289214e4c8d382791c9c93bbc3028a3309"
    }
  },
  {
    "ts": null,
    "headline": "Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger",
    "summary": "Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment analysis of WAT stock.",
    "url": "https://finnhub.io/api/news?id=6ad51a9650e3d9e1d899c0cf60839daf360c2b06f05648a318bb196f44e3f74c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752541243,
      "headline": "Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger",
      "id": 135933784,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189337416/image_2189337416.jpg?io=getty-c-w1536",
      "related": "WAT",
      "source": "SeekingAlpha",
      "summary": "Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment analysis of WAT stock.",
      "url": "https://finnhub.io/api/news?id=6ad51a9650e3d9e1d899c0cf60839daf360c2b06f05648a318bb196f44e3f74c"
    }
  }
]